TrialMolecular oncology2025

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial-mesenchymal transition and tumor-infiltrating lymphocytes.

Françoise Derouane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.